This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

A Breakthrough in the Pharmacologic Management of Insomnia: Overview of the Clinical Profile of Zaleplon

Raymond Cluydts, PhD

Published: April 18, 2002

Article Abstract

Insomnia is associated with an increase in the risk of depression and accidents and in utilization of health care and also a decrease in cognition, productivity, and quality of life. The need is evident for an advanced sleep medication that acts quickly, produces no next-day residual effects, and avoids the development of withdrawal effects. Zaleplon is a novel sleep medication that rapidly induces sleep with minimal residual sedation or impairment of psychomotor and cognitive skills. The unique characteristics of zaleplon are believed to be related to a combination of its low receptor-binding affinity and its rapid elimination. Accordingly, studies have shown that zaleplon can be safe and effective for sleep induction whether taken at bedtime or during the night, which makes zaleplon a distinctly versatile tool for the pharmacologic management of insomnia.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 4

Quick Links: Sleep-Wake

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...